Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-26

Clinical Trial Update: Vinorelbine in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating vinorelbine in metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED